You are here

Carlos Gomez-Roca (FR)

Carlos Gomez-Roca is a tenure-track and full-time cancer specialist at the Institut Universitaire du Cancer de Toulouse (IUCT). Dr. Gomez-Roca trained as internal medicine specialist at Instituto Universitario CEMIC at Buenos Aires (Argentina) and obtained his degree with honors in 2005. He obtained his diploma as medical oncologist at Paris-Sud Medical School (France) in 2007 and completes his Master in Oncology on 2008 at the same university.

Dr. Gomez-Roca is currently Co-chair of the Clinical Research Unit at IUCT-Oncopole and leader in the Early Phase Unit with a focus on targeted therapies and immune-oncology. His main research interests are early clinical development, phase I trials across solid tumors, innovative methods of evaluation of novel drugs’ clinical activity, personalized medicine and mechanisms of toxicities of new targeted agents and immunotherapies. He is also involved in translational research aspects related to interaction of immune-oncology agents and radiotherapy. Dr Gomez-Roca is member of ESMO, ASCO and AACR. He contributed to more than 40 peer-reviewed publications including publications as first or second author in the Journal of Clinical Oncology and Annals of Oncology.

November 11, 2017
2:00pm to 3:30pm Emerging diagnostics and therapeutics Warsaw III Shabbir Alibhai (CA), Carlos Gomez-Roca (FR), Armin Shahrokni (US), Alastair Greystoke (GB), Charles Kelly (GB)